Surgeons at Balbala Hospital in Djibouti City saw 102 women with breast cancer between 2012 and 2017, and 86 of them accepted an operation. The authors wrote that Djibouti had no radiotherapy or chemotherapy facilities at the time, and that tamoxifen was available.
Indexed as "Current practice in diagnosis and treatment of breast cancer in Cheicko Balbala Hospital Djibouti" (Ann Ital Chir 2020; 91: 592 to 597). The authors call it the first breast cancer prevalence study done in Djibouti; it is a single hospital's surgical series, not a population study. All patients came directly to the hospital without a prior referral. OnCo read the abstract as indexed by Europe PMC; the paper has no DOI there.
It is a rare published count of breast cancer care inside Djibouti, and it records that surgery and tamoxifen were what the hospital could offer in those years. The authors ask for better information for the public and for general practitioners so that women are diagnosed earlier.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/